Overview Dividends

(RYAN) Ryan Specialty Holdings - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US78351F1075

Specialty Insurance, Wholesale Brokerage, Managing Underwriting, Risk Management

Insurance Brokers
Market Cap in USD: 13,383m

IPO / Inception: 2021-07-22
Return 12m vs S&P 500: -29.9%

EPS (Earnings per Share)

EPS CAGR: -41.54%
EPS Trend: 21.0%

Last SUE: -4.00
Qual. Beats: 0

Revenue

Rev. CAGR: 20.20%
Rev. Trend: 93.2%

Last SUE: 1.27
Qual. Beats: 2

Dividends

Dividend Yield	0.95%
Yield on Cost 5y	1.78%
Yield CAGR 5y	-14.29%
Payout Consistency	93.8%
Payout Ratio	24.4%

Risk via 5d forecast
Volatility	34.8%
Value at Risk 5%th	53.9%
Relative Tail Risk	-5.89%

Reward TTM
Sharpe Ratio	-0.54
Alpha	-27.59
CAGR/Max DD	0.18

Character TTM
Hurst Exponent	0.471
Beta	0.421
Beta Downside	0.452

Drawdowns 3y
Max DD	33.38%
Mean DD	9.57%
Median DD	7.20%

Description: RYAN Ryan Specialty Holdings January 02, 2026

Ryan Specialty Group Holdings Inc. (NYSE:RYAN) is a Chicago-based wholesale broker and managing underwriter that delivers specialty insurance products and risk-management services to brokers, agents, and carriers across North America, Europe, and Asia-Pacific. Founded in 2010, the firm focuses on commercial, industrial, institutional, and government clients, handling distribution, underwriting, product development, administration, and claims management.

Key metrics from the most recent fiscal year show FY2023 revenue of roughly $1.5 billion, a combined ratio of 92.5 % (indicating underwriting profitability), and a 12 % year-over-year increase in net income driven by growth in cyber-risk and construction-related lines. The specialty broker sector is currently being shaped by rising commercial insurance demand, tighter capacity in traditional markets, and heightened regulatory scrutiny on pricing and reserving practices.

For a deeper quantitative view, you might explore ValueRay’s analytics platform to assess how Ryan’s valuation compares to sector peers.

Piotroski VR‑10 (Strict, 0-10) 3.5

Net Income (69.2m TTM) > 0 and > 6% of Revenue (6% = 176.1m TTM)

FCFTA 0.06 (>2.0%) and ΔFCFTA 0.63pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue -0.34% (prev 2.24%; Δ -2.59pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.06 (>3.0%) and CFO 640.1m > Net Income 69.2m (YES >=105%, WARN >=100%)

Net Debt (3.42b) to EBITDA (892.4m) ratio: 3.83 <= 3.0 (WARN <= 3.5)

Current Ratio 1.00 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (273.5m) change vs 12m ago 0.28% (target <= -2.0% for YES)

Gross Margin 42.12% (prev 39.15%; Δ 2.97pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 32.03% (prev 28.11%; Δ 3.91pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 2.83 (EBITDA TTM 892.4m / Interest Expense TTM 217.7m) >= 6 (WARN >= 3)

Altman Z'' 0.50

(A) -0.00 = (Total Current Assets 4.45b - Total Current Liabilities 4.46b) / Total Assets 9.85b

(B) 0.01 = Retained Earnings (Balance) 128.8m / Total Assets 9.85b

(D) 0.02 = Book Value of Equity 140.2m / Total Liabilities 8.62b

Total Rating: 0.50 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 71.01

1. Piotroski 3.50pt

2. FCF Yield 3.40%

3. FCF Margin 19.49%

4. Debt/Equity 5.67

5. Debt/Ebitda 3.83

6. ROIC - WACC (= 9.54)%

7. RoE 11.48%

8. Rev. Trend 93.20%

9. EPS Trend 21.03%

What is the price of RYAN shares?

As of January 09, 2026, the stock is trading at USD 50.29 with a total of 1,047,756 shares traded.
Over the past week, the price has changed by -0.63%, over one month by -6.63%, over three months by -13.55% and over the past year by -17.09%.

Is RYAN a buy, sell or hold?

Ryan Specialty Holdings has received a consensus analysts rating of 3.92. Therefore, it is recommended to buy RYAN.

Strong Buy: 4
Buy: 5
Hold: 3
Sell: 1
Strong Sell: 0

What are the forecasts/targets for the RYAN price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	65.6	30.5%
Analysts Target Price	65.6	30.5%
ValueRay Target Price	51.2	1.8%

RYAN Fundamental Data Overview January 04, 2026

P/E Trailing = 95.4906
P/E Forward = 21.9298
P/S = 4.6055
P/B = 10.5456
Beta = 0.611
Revenue TTM = 2.94b USD
EBIT TTM = 615.3m USD
EBITDA TTM = 892.4m USD
Long Term Debt = 3.35b USD (from longTermDebt, last quarter)
Short Term Debt = 66.4m USD (from shortTermDebt, last quarter)
Debt = 3.58b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.42b USD (from netDebt column, last quarter)
Enterprise Value = 16.80b USD (13.38b + Debt 3.58b - CCE 153.5m)
Interest Coverage Ratio = 2.83 (Ebit TTM 615.3m / Interest Expense TTM 217.7m)
FCF Yield = 3.40% (FCF TTM 572.1m / Enterprise Value 16.80b)
FCF Margin = 19.49% (FCF TTM 572.1m / Revenue TTM 2.94b)
Net Margin = 2.36% (Net Income TTM 69.2m / Revenue TTM 2.94b)
Gross Margin = 42.12% ((Revenue TTM 2.94b - Cost of Revenue TTM 1.70b) / Revenue TTM)
Gross Margin QoQ = 47.57% (prev 43.25%)
Tobins Q-Ratio = 1.71 (Enterprise Value 16.80b / Total Assets 9.85b)
Interest Expense / Debt = 1.58% (Interest Expense 56.3m / Debt 3.58b)
Taxrate = -4.68% (negative due to tax credits) (-2.80m / 59.8m)
NOPAT = 644.1m (EBIT 615.3m * (1 - -4.68%)) [negative tax rate / tax credits]
Current Ratio = 1.00 (Total Current Assets 4.45b / Total Current Liabilities 4.46b)
Debt / Equity = 5.67 (Debt 3.58b / totalStockholderEquity, last quarter 630.5m)
Debt / EBITDA = 3.83 (Net Debt 3.42b / EBITDA 892.4m)
Debt / FCF = 5.98 (Net Debt 3.42b / FCF TTM 572.1m)
Total Stockholder Equity = 602.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.75% (Net Income 69.2m / Total Assets 9.85b)
RoE = 11.48% (Net Income TTM 69.2m / Total Stockholder Equity 602.7m)
RoCE = 15.57% (EBIT 615.3m / Capital Employed (Equity 602.7m + L.T.Debt 3.35b))
RoIC = 15.86% (NOPAT 644.1m / Invested Capital 4.06b)
WACC = 6.32% (E(13.38b)/V(16.96b) * Re(7.57%) + D(3.58b)/V(16.96b) * Rd(1.58%) * (1-Tc(-0.05)))
Discount Rate = 7.57% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -29.29%
[DCF Debug] Terminal Value 86.82% ; FCFF base≈518.7m ; Y1≈610.3m ; Y5≈933.6m
Fair Price DCF = 164.0 (EV 24.54b - Net Debt 3.42b = Equity 21.12b / Shares 128.8m; r=6.32% [WACC]; 5y FCF grow 18.81% → 3.0% )
EPS Correlation: 21.03 | EPS CAGR: -41.54% | SUE: -4.0 | # QB: 0
Revenue Correlation: 93.20 | Revenue CAGR: 20.20% | SUE: 1.27 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.47 | Chg30d=-0.003 | Revisions Net=+0 | Analysts=14
EPS next Year (2026-12-31): EPS=2.41 | Chg30d=-0.021 | Revisions Net=+0 | Growth EPS=+19.7% | Growth Revenue=+17.0%

Additional Sources for RYAN Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle